Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 Next >
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags Breaking news Companies Health & Science
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
Tags LVMH Moet Hennessy Louis Vuitton SE Breaking News: Economy Novo Nordisk A/S
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Investment strategy Investing Business News
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Eli Lilly and Co Eisai Co Ltd Biotech and Pharmaceuticals
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Companies Science Weight management
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Business News US: News Biotechnology
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Biotechnology US: News Business News
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags U/S/ Markets Stock Picks Novo Nordisk A/S
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Biotech and Pharmaceuticals Business Eli Lilly and Co
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Politics Technology
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Health & Science Health care industry Business News
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
Tags Business Markets Stock markets
From CNBC.com News
Cramer's Lightning Round: Buy AutoZone
Tags Aehr Test Systems Autozone Inc Stock Picks
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Biotechnology Social issues US: News
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Tags Health care industry Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Breaking news Companies Novo Nordisk A/S
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags Europe News Biotech and Pharmaceuticals Business
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Business Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags Companies Breaking news Spin/offs
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Technology Dexcom Inc Weight management
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
Tags Novo Nordisk A/S Advanced Micro Devices Inc Exxon Mobil Corp
From CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
Tags Daily Open Alphabet Inc Arm Holdings PLC
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Tags Eli Lilly and Co Investment strategy Health & Science
From CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
Tags Biotechnology US: News Walmart Inc
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Investment strategy Finance Breaking News: Markets
From CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
Tags Companies Breaking news Health & Science
From CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Tickers BIRK EVS MSFT NVO
Tags Equities Market News Novo Nordisk
From Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
Tags Business Stock markets Markets
From CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
Tags Pioneer Natural Resources Co Amgen Inc Eli Lilly and Co
From CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
Tags Novo Nordisk A/S Exxon Mobil Corp Market Insider
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.